Assay ID | Title | Year | Journal | Article |
AID1079940 | Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source] | | | |
AID283577 | Reduction of NF-kappaB binding to DNA in cystic fibrosis IB3-1 cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
AID283578 | Reduction of NF-kappaB binding to DNA in cystic fibrosis 16HBE14o-AS3 cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
AID1064175 | Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID556348 | Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method | 2009 | Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
| Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. |
AID1137040 | Displacement of [14C]erythromycin from Escherichia coli ribosomes after 30 mins by scintillation spectrometer analysis | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5
| Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes. |
AID423272 | Antibacterial activity against 0.01 MOI wild type Chlamydia trachomatis L2/LGV/434/Bu infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID1079937 | Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source] | | | |
AID369233 | Antibacterial activity against macrolide-resistant Streptococcus pneumoniae isolates by double-disk diffusion method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID1064178 | Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 15 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID422942 | Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method | 2008 | Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
| Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. |
AID1064177 | Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 09-6 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID556350 | Antimicrobial activity against Mycoplasma pneumoniae clinical isolate harboring point mutations in 23S rRNA at positions 2063 and 2064 isolated from human respiratory tract by microdilution method | 2009 | Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
| Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. |
AID283582 | Reduction of Sp1 binding to DNA in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
AID1079936 | Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source] | | | |
AID1079942 | Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source] | | | |
AID1137039 | Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 by agar dilution method | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5
| Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes. |
AID369227 | Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID1064173 | Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis 09-9 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID423273 | Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#23 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID369228 | Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID1079946 | Presence of at least one case with successful reintroduction. [column 'REINT' in source] | | | |
AID529868 | Antimicrobial activity against Escherichia coli AG100A harboring pAT392 containing rdmC-like gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID283558 | Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli. |
AID1079939 | Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source] | | | |
AID1079944 | Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source] | | | |
AID423274 | Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#31 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID520741 | Antimicrobial activity against cfr-deficient Staphylococcus aureus RN4220 harboring erm(B) gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
| Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. |
AID518965 | Induction of erm(C) expression in Escherichia coli JM109 harboring Staphylococcus aureus erm(C)-containing pERMZalpha reporter plasmid at 10 mg/ml after 36 hrs at 37 degC by disc-based beta-galactosidase reporter gene assay | 2008 | Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
| Induction of erm(C) expression by noninducing antibiotics. |
AID520740 | Antimicrobial activity against erm(B)-deficient Staphylococcus aureus RN4220 harboring cfr gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
| Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. |
AID1064174 | Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 09-3 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID529875 | Antimicrobial activity against Enterococcus faecalis JH2-2 harboring pAT392 containing mph(B) gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID422943 | Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method | 2008 | Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
| Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. |
AID529866 | Antimicrobial activity against Streptococcus uberis UCN60 expressing mph(B) and rdmC-like genes by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID520736 | Antimicrobial activity against erm(B) and cfr-deficient Staphylococcus aureus RN4220 harboring plasmid LI50 by disk diffusion assay | 2008 | Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
| Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. |
AID422944 | Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method | 2008 | Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
| Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. |
AID529879 | Antimicrobial activity against Enterococcus faecalis JH2-2 harboring empty vector by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID1137038 | Antimicrobial activity against Bacillus subtilis ATCC 6633 by agar dilution method | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5
| Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes. |
AID529877 | Antimicrobial activity against Escherichia coli AG100A harboring empty vector by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID520735 | Antimicrobial activity against Staphylococcus aureus RN4220 harboring erm(B) and cfr gene by disk diffusion assay | 2008 | Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
| Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. |
AID1079941 | Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source] | | | |
AID369232 | Antibacterial activity against inducible macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae isolates by double-disk diffusion method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID1064176 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus 09-13 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID369230 | Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID423265 | Antibacterial activity against 0.01 MOI wild type Chlamydia psittaci 6BC BCRB infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID1424059 | Induction of ribosome stalling assessed as induction of stalling of ribosome at ermBL ORF at 50 uM by extension inhibition assay | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture. |
AID1079935 | Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source] | | | |
AID1079949 | Proposed mechanism(s) of liver damage. [column 'MEC' in source] | | | |
AID1079932 | Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source] | | | |
AID529876 | Antimicrobial activity against Enterococcus faecalis JH2-2 harboring pAT392 containing mph(B) and rdmC-like gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID423268 | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ1 harboring A2059G mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID1079938 | Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source] | | | |
AID283560 | Antibacterial activity against Escherichia coli HNCE4 after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli. |
AID423266 | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ2 harboring A2058C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID529867 | Antimicrobial activity against Streptococcus uberis UCN61 by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID529872 | Antimicrobial activity against Staphylococcus aureus RN4220 harboring pAT392 containing mph(B) gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID283559 | Antibacterial activity against Escherichia coli AG102MB after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli. |
AID1079945 | Animal toxicity known. [column 'TOXIC' in source] | | | |
AID1137037 | Antimicrobial activity against Staphylococcus aureus ATCC 6538P by agar dilution method | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5
| Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes. |
AID556351 | Antimicrobial activity against Mycoplasma pneumoniae FH by microdilution method | 2009 | Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
| Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. |
AID556349 | Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method | 2009 | Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
| Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. |
AID519669 | Inhibition of PAR2-mediated SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes preincubated for 24 hrs by ELISA | 2008 | Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
| Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. |
AID369229 | Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID529869 | Antimicrobial activity against Escherichia coli AG100A harboring pAT392 containing mph(B) gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID1079947 | Comments (NB not yet translated). [column 'COMMENTAIRES' in source] | | | |
AID1079948 | Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source] | | | |
AID678738 | TP_TRANSPORTER: inhibition of Vinblastine efflux (Vinblastine: 0.002 uM, Josamycin: 100 uM) in P388/S and P388/ADR cells | 2000 | Clinical and experimental pharmacology & physiology, Aug, Volume: 27, Issue:8
| Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. |
AID283581 | Reduction of Sp1 binding to DNA in cystic fibrosis 16HBE14o-AS3 cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
AID1079934 | Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source] | | | |
AID678748 | TP_TRANSPORTER: inhibition of Cyclosporin A efflux (CsA: 0.005 uM, Josamycin: 100 uM) in P388/S and P388/ADR cells | 2000 | Clinical and experimental pharmacology & physiology, Aug, Volume: 27, Issue:8
| Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. |
AID1064180 | Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID1079931 | Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source] | | | |
AID529870 | Antimicrobial activity against Escherichia coli AG100A harboring pAT392 containing mph(B) and rdmC-like genes by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID283579 | Reduction of NF-kappaB binding to DNA in cystic fibrosis 2CFSMEo cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
AID529874 | Antimicrobial activity against Enterococcus faecalis JH2-2 harboring pAT392 containing rdmC-like gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID1424070 | In-vitro inhibition of protein translation using pY71-sfGFP in PUREexpress in vitro protein synthesis system assessed as reduction in cell-free GFP protein translation at 50 uM measured every 20 mins for 2 hrs | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture. |
AID529871 | Antimicrobial activity against Staphylococcus aureus RN4220 harboring pAT392 containing rdmC-like gene by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID423267 | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ5 harboring A2059C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | 2007 | Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
| Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
AID529873 | Antimicrobial activity against Staphylococcus aureus RN4220 harboring pAT392 containing mph(B) and rdmC-like genes by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID529878 | Antimicrobial activity against Staphylococcus aureus RN4220 harboring empty vector by broth microdilution method | 2008 | Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
| Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
AID1064179 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by broth microdilution method | 2014 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
| Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. |
AID1079933 | Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is | | | |
AID1079943 | Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source] | | | |
AID369231 | Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae isolates by double-disk diffusion method | 2007 | Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
| Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. |
AID283580 | Reduction of Sp1 binding to DNA in cystic fibrosis IB3-1 cells at 8 ug after 24 hrs | 2007 | Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |